DNA-tumor virus entry-From plasma membrane to the nucleus

Seminars in Cell and Developmental Biology

Volumn 20, Issue 5, 2009, Pages 631-642

  Puntener, Daniel ^a   Greber, Urs F ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cell transformation; Cytoplasmic transport; Nuclear pore complex; Nucleocytoplasmic transport; Virus entry

Indexed keywords

DNA BINDING PROTEIN; KARYOPHERIN ALPHA; KARYOPHERIN BETA; NUCLEOPORIN; RAN PROTEIN; VIRUS PROTEIN;

ADENOVIRUS; CELL MEMBRANE; CELL NUCLEUS; CHROMATIN; DNA PROTEIN COMPLEX; DNA TUMOR VIRUS; HEPADNAVIRUS; HERPES SIMPLEX VIRUS 1; HUMAN; MICROTUBULE; NONHUMAN; NUCLEAR IMPORT; NUCLEAR PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; PAPILLOMA VIRUS; POLYOMA VIRUS; REVIEW; RNA TUMOR VIRUS; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS MUTANT; VIRUS REPLICATION;

PAPILLOMAVIRIDAE; POLYOMAVIRUS;

EID: 67649422214     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2009.03.014     Document Type: Review

References (230)

1. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118 12 (2006) 3030-3044
2. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2 5 (2002) 342-350
3. Pagano J.S., Blaser M., Buendia M.A., Damania B., Khalili K., Raab-Traub N., et al. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 14 6 (2004) 453-471
4. McLaughlin-Drubin M.E., and Munger K. Viruses associated with human cancer. Biochim Biophys Acta 1782 3 (2008) 127-150
5. Javier R.T., and Butel J.S. The history of tumor virology. Cancer Res 68 19 (2008) 7693-7706
6. Carbone M, Barbanti-Brodano MG. Viral carcinogenesis. In: al. AECe, editor. Oncology, an evidence-based approach. New York: Springer; 2006. p. 214-32.
7. Trentin J.J., Yabe Y., and Taylor G. The quest for human cancer viruses. Science 137 (1962) 835-841
8. Dörfler W. The fate of the DNA of adenovirus type 12 in baby hamster kidney cells. Proc Natl Acad Sci USA 60 (1968) 636-643
9. Kosulin K., Haberler C., Hainfellner J.A., Amann G., Lang S., and Lion T. Investigation of adenovirus occurrence in pediatric tumor entities. J Virol 81 14 (2007) 7629-7635
10. Knipe D.M., and Cliffe A. Chromatin control of herpes simplex virus lytic and latent infection. Nat Rev Microbiol 6 3 (2008) 211-221
11. Cesarman E., and Mesri E.A. Kaposi sarcoma-associated herpesvirus and other viruses in human lymphomagenesis. Curr Top Microbiol Immunol 312 (2007) 263-287
12. Molho-Pessach V., and Lotem M. Viral carcinogenesis in skin cancer. Curr Probl Dermatol 35 (2007) 39-51
13. Osterrieder N., Kamil J.P., Schumacher D., Tischer B.K., and Trapp S. Marek's disease virus: from miasma to model. Nat Rev Microbiol 4 4 (2006) 283-294
14. Miller G. Brain cancer. A viral link to glioblastoma?. Science 323 5910 (2009) 30-31
15. Epstein M.A., Henle G., Achong B.G., and Barr Y.M. Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt's lymphoma. J Exp Med 121 (1965) 761-770
16. Hebner C.M., and Laimins L.A. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol 16 2 (2006) 83-97
17. Roberts J.N., Buck C.B., Thompson C.D., Kines R., Bernardo M., Choyke P.L., et al. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 13 7 (2007) 857-861
18. Girardi A.J., Sweet B.H., Slotnick V.B., and Hilleman M.R. Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV-40. Proc Soc Exp Biol Med 109 (1962) 649-660
19. White M.K., Gordon J., Reiss K., Del Valle L., Croul S., Giordano A., et al. Human polyomaviruses and brain tumors. Brain Res Brain Res Rev 50 1 (2005) 69-85
20. Feng H., Shuda M., Chang Y., and Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319 5866 (2008) 1096-1100
21. Pungpapong S., Kim W.R., and Poterucha J.J. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc 82 8 (2007) 967-975
22. Greber U.F., and Fassati A. Nuclear import of viral DNA genomes. Traffic 4 (2003) 136-143
23. Pouton C.W., Wagstaff K.M., Roth D.M., Moseley G.W., and Jans D.A. Targeted delivery to the nucleus. Adv Drug Deliv Rev 59 8 (2007) 698-717
24. Alvisi G., Rawlinson S.M., Ghildyal R., Ripalti A., and Jans D.A. Regulated nucleocytoplasmic trafficking of viral gene products: a therapeutic target?. Biochim Biophys Acta 1784 1 (2008) 213-227
25. Fontoura B.M., Faria P.A., and Nussenzveig D.R. Viral interactions with the nuclear transport machinery: discovering and disrupting pathways. IUBMB Life 57 2 (2005) 65-72
26. Dobner T., and Kzhyshkowska J. Nuclear export of adenovirus RNA. Curr Top Microbiol Immunol 259 (2001) 25-54
27. Sandri-Goldin R.M. Nuclear export of herpes virus RNA. Curr Top Microbiol Immunol 259 (2001) 2-23
28. Mettenleiter T.C., Klupp B.G., and Granzow H. Herpesvirus assembly: a tale of two membranes. Curr Opin Microbiol 9 4 (2006) 423-429
29. Sommer G., and Heise T. Posttranscriptional control of HBV gene expression. Front Biosci 13 (2008) 5533-5547
30. Jiang M., Abend J.R., Johnson S.F., and Imperiale M.J. The role of polyomaviruses in human disease. Virology (2008)
31. Lopez-Bueno A., Villarreal L.P., and Almendral J.M. Parvovirus variation for disease: a difference with RNA viruses?. Curr Top Microbiol Immunol 299 (2006) 349-370
32. Sieczkarski S.B., and Whittaker G.R. Viral entry. Curr Top Microbiol Immunol 285 (2005) 1-23
33. Marsh M., and Helenius A. Virus entry: open sesame. Cell 124 4 (2006) 729-740
34. Greber U.F., and Gastaldelli M. Junctional gating: the Achilles' heel of epithelial cells in pathogen infection. Cell Host Microbe 2 (2007) 143-146
35. Pedersen S.M., and Hollsberg P. Complexities in human herpesvirus-6A and -6B binding to host cells. Virology 356 1-2 (2006) 1-3
36. Heldwein E.E., and Krummenacher C. Entry of herpesviruses into mammalian cells. Cell Mol Life Sci 65 11 (2008) 1653-1668
37. Stanley M.A., Pett M.R., and Coleman N. HPV: from infection to cancer. Biochem Soc Trans 35 Pt 6 (2007) 1456-1460
38. Dugan A.S., Eash S., and Atwood W.J. Update on BK virus entry and intracellular trafficking. Transpl Infect Dis 8 2 (2006) 62-67
39. Glebe D., and Urban S. Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13 1 (2007) 22-38
40. Young K.A., Herbert A.P., Barlow P.N., Holers V.M., and Hannan J.P. Molecular basis of the interaction between complement receptor type 2 (CR2/CD21) and Epstein-Barr virus glycoprotein gp350. J Virol 82 22 (2008) 11217-11227
41. Sherer N.M., and Mothes W. Cytonemes and tunneling nanotubules in cell-cell communication and viral pathogenesis. Trends Cell Biol 18 9 (2008) 414-420
42. Sattentau Q. Avoiding the void: cell-to-cell spread of human viruses. Nat Rev Microbiol 6 11 (2008) 815-826
43. Mansouri M., Rose P.P., Moses A.V., and Fruh K. Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus. J Virol 82 19 (2008) 9615-9628
44. Lara-Pezzi E., Gomez-Gaviro M.V., Galvez B.G., Mira E., Iniguez M.A., Fresno M., et al. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest 110 12 (2002) 1831-1838
45. Lee J.O., Kwun H.J., Jung J.K., Choi K.H., Min D.S., and Jang K.L. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 24 44 (2005) 6617-6625
46. Meier O., and Greber U.F. Adenovirus endocytosis. J Gene Med 5 (2003) 451-462
47. Gastaldelli M., Imelli N., Boucke K., Amstutz B., Meier O., and Greber U.F. Infectious adenovirus Type 2 transport through early but not late endosomes. Traffic 9 12 (2008) 2265-2278
48. Amstutz B., Gastaldelli M., Kälin S., Imelli N., Boucke K., Wandeler E., et al. Subversion of CtBP1 controlled macropinocytosis by human Adenovirus serotype 3. EMBO J 27 7 (2008) 956-966
49. Akula S.M., Naranatt P.P., Walia N.S., Wang F.Z., Fegley B., and Chandran B. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis. J Virol 77 14 (2003) 7978-7990
50. Rappocciolo G., Hensler H.R., Jais M., Reinhart T.A., Pegu A., Jenkins F.J., et al. Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. J Virol 82 10 (2008) 4793-4806
51. Lin C.T., Lin C.R., Tan G.K., Chen W., Dee A.N., and Chan W.Y. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells. Am J Pathol 150 5 (1997) 1745-1756
52. Spoden G., Freitag K., Husmann M., Boller K., Sapp M., Lambert C., et al. Clathrin- and caveolin-independent entry of human papillomavirus type 16-involvement of tetraspanin-enriched microdomains (TEMs). PLoS ONE 3 10 (2008) e3313
53. Querbes W., O'Hara B.A., Williams G., and Atwood W.J. Invasion of host cells by JC virus identifies a novel role for caveolae in endosomal sorting of noncaveolar ligands. J Virol 80 19 (2006) 9402-9413
54. Damm E.M., and Pelkmans L. Systems biology of virus entry in mammalian cells. Cell Microbiol 8 8 (2006) 1219-1227
55. Funk A., Mhamdi M., Hohenberg H., Will H., and Sirma H. pH-independent entry and sequential endosomal sorting are major determinants of hepadnaviral infection in primary hepatocytes. Hepatology 44 3 (2006) 685-693
56. Cooper A., Paran N., and Shaul Y. The earliest steps in hepatitis B virus infection. Biochim Biophys Acta 1614 1 (2003) 89-96
57. Greber U.F., Singh I., and Helenius A. Mechanisms of virus uncoating. Trends Microbiol 2 (1994) 52-56
58. Greber U.F. Signalling in viral entry. Cell Mol Life Sci 59 (2002) 608-626
59. Schelhaas M., Malmstrom J., Pelkmans L., Haugstetter J., Ellgaard L., Grunewald K., et al. Simian Virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell 131 3 (2007) 516-529
60. Burckhardt C.J., and Greber U.F. Redox rescues virus from ER trap. Nat Cell Biol 10 1 (2008) 9-11
61. Selinka H.C., Giroglou T., and Sapp M. Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. Virology 299 2 (2002) 279-287
62. Richards R.M., Lowy D.R., Schiller J.T., and Day P.M. Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci USA 103 5 (2006) 1522-1527
63. Day P.M., Baker C.C., Lowy D.R., and Schiller J.T. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci USA 101 39 (2004) 14252-14257
64. Mabit H., Nakano M.Y., Prank U., Saam B., Döhner K., Sodeik B., et al. Intact microtubules support Adenovirus and Herpes simplex virus infections. J Virol 76 (2002) 9962-9971
65. Sodeik B., Ebersold M.W., and Helenius A. Microtubule-mediated transport of incoming Herpes Simplex Virus 1 capsids to the nucleus. J Cell Biol 136 5 (1997) 1007-1021
66. Suomalainen M., Nakano M.Y., Boucke K., Keller S., and Greber U.F. Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. EMBO J 20 6 (2001) 1310-1319
67. Suomalainen M., Nakano M.Y., Boucke K., Keller S., Stidwill R.P., and Greber U.F. Microtubule-dependent minus and plus end-directed motilities are competing processes for nuclear targeting of adenovirus. J Cell Biol 144 (1999) 657-672
68. Kelkar S.A., Pfister K.K., Crystal R.G., and Leopold P.L. Cytoplasmic dynein mediates adenovirus binding to microtubules. J Virol 78 18 (2004) 10122-10132
69. Smith J.G., Cassany A., Gerace L., Ralston R., and Nemerow G.R. A neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport. J Virol (2008)
70. Greber U.F., and Way M. A super highway to virus infection. Cell 124 4 (2006) 741-754
71. Leopold P.L., and Pfister K.K. Viral strategies for intracellular trafficking: motors and microtubules. Traffic 7 5 (2006) 516-523
72. Radtke K., Dohner K., and Sodeik B. Viral interactions with the cytoskeleton: a hitchhiker's guide to the cell. Cell Microbiol 8 3 (2006) 387-400
73. Douglas M.W., Diefenbach R.J., Homa F.L., Miranda-Saksena M., Rixon F.J., Vittone V., et al. Herpes simplex virus type 1 capsid protein VP26 interacts with dynein light chains RP3 and Tctex1 and plays a role in retrograde cellular transport. J Biol Chem 279 27 (2004) 28522-28530
74. Greber U.F. Viral trafficking violations in axons-the herpes virus case. Proc Natl Acad Sci USA 102 16 (2005) 5639-5640
75. Gaspar M., Gill M.B., Losing J.B., May J.S., and Stevenson P.G. Multiple functions for ORF75c in murid herpesvirus-4 infection. PLoS ONE 3 7 (2008) e2781
76. Luxton G.W., Haverlock S., Coller K.E., Antinone S.E., Pincetic A., and Smith G.A. Targeting of herpesvirus capsid transport in axons is coupled to association with specific sets of tegument proteins. Proc Natl Acad Sci USA 102 16 (2005) 5832-5837
77. Nagel C.H., Dohner K., Fathollahy M., Strive T., Borst E.M., Messerle M., et al. Nuclear egress and envelopment of herpes simplex virus capsids analyzed with dual-color fluorescence HSV1(17+). J Virol 82 6 (2008) 3109-3124
78. Wolfstein A., Nagel C.H., Radtke K., Dohner K., Allan V.J., and Sodeik B. The inner tegument promotes herpes simplex virus capsid motility along microtubules in vitro. Traffic 7 2 (2006) 227-237
79. Delboy M.G., Roller D.G., and Nicola A.V. Cellular proteasome activity facilitates herpes simplex virus entry at a postpenetration step. J Virol 82 7 (2008) 3381-3390
80. Gundersen G.G. Microtubule capture: IQGAP and CLIP-170 expand the repertoire. Curr Biol 12 19 (2002) R645-647
81. Warren J.C., and Cassimeris L. The contributions of microtubule stability and dynamic instability to adenovirus nuclear localization efficiency. Cell Motil Cytoskeleton 64 9 (2007) 675-689
82. Giannakakou P., Nakano M., Nicolaou K.C., O'Brate A., Yu J., Blagosklonny M.V., et al. Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics. Proc Natl Acad Sci USA 99 16 (2002) 10855-10860
83. Warren J.C., Rutkowski A., and Cassimeris L. Infection with replication-deficient adenovirus induces changes in the dynamic instability of host cell microtubules. Mol Biol Cell 17 8 (2006) 3557-3568
84. Naranatt P.P., Krishnan H.H., Smith M.S., and Chandran B. Kaposi's sarcoma-associated herpesvirus modulates microtubule dynamics via RhoA-GTP-diaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to the nucleus. J Virol 79 2 (2005) 1191-1206
85. Akula S.M., Pramod N.P., Wang F.Z., and Chandran B. Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells. Cell 108 3 (2002) 407-419
86. Stewart P.L., and Nemerow G.R. Cell integrins: commonly used receptors for diverse viral pathogens. Trends Microbiol 15 11 (2007) 500-507
87. Raghu H., Sharma-Walia N., Veettil M.V., Sadagopan S., Caballero A., Sivakumar R., et al. Lipid rafts of primary endothelial cells are essential for Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-induced phosphatidylinositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear delivery of viral DNA but dispensable for binding and entry. J Virol 81 15 (2007) 7941-7959
88. Miller N., and Hutt-Fletcher L.M. Epstein-Barr virus enters B cells and epithelial cells by different routes 66 (1992) 3409-3414
89. Nemerow G.R., and Cooper N.R. Early events in the infection of human B lymphocytes by Epstein-Barr virus: the internalization process. Virology 132 1 (1984) 186-198
90. Leopold P.L., Kreitzer G., Miyazawa N., Rempel S., Pfister K.K., Rodriguez-Boulan E., et al. Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum Gene Ther 11 1 (2000) 151-165
91. Dohner K., Wolfstein A., Prank U., Echeverri C., Dujardin D., Vallee R., et al. Function of dynein and dynactin in herpes simplex virus capsid transport. Mol Biol Cell 13 8 (2002) 2795-2809
92. Schroer T.A. Dynactin. Annu Rev Cell Dev Biol 20 (2004) 759-779
93. Florin L., Becker K.A., Lambert C., Nowak T., Sapp C., Strand D., et al. Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2. J Virol 80 13 (2006) 6691-6696
94. Gross S.P., Welte M.A., Block S.M., and Wieschaus E.F. Coordination of opposite-polarity microtubule motors. J Cell Biol 156 4 (2002) 715-724
95. Deacon S.W., Serpinskaya A.S., Vaughan P.S., Lopez Fanarraga M., Vernos I., Vaughan K.T., et al. Dynactin is required for bidirectional organelle transport. J Cell Biol 160 3 (2003) 297-301
96. Shubeita G.T., Tran S.L., Xu J., Vershinin M., Cermelli S., Cotton S.L., et al. Consequences of motor copy number on the intracellular transport of kinesin-1-driven lipid droplets. Cell 135 6 (2008) 1098-1107
97. Ally S, Larson AG, Barlan K, Rice S, Gelfand V. Mechanical cross-talk between Kinesin-1 and cytoplasmic dynein in vivo. Mol Cell Biol 2008;19(Suppl.) [abstract no. 1547].
98. Strunze S., Trotman L.C., Boucke K., and Greber U.F. Nuclear targeting of adenovirus type 2 requires CRM1-mediated nuclear export. Mol Biol Cell 16 6 (2005) 2999-3009
99. Joseph J., and Dasso M. The nucleoporin Nup358 associates with and regulates interphase microtubules. FEBS Lett 582 2 (2008) 190-196
100. Magnuson B., Rainey E.K., Benjamin T., Baryshev M., Mkrtchian S., and Tsai B. ERp29 triggers a conformational change in polyomavirus to stimulate membrane binding. Mol Cell 20 2 (2005) 289-300
101. Greber U.F., and Kasamatsu H. Nuclear targeting of adenovirus and simian virus SV40. Trends Cell Biol 6 (1996) 189-195
102. Whittaker G.R., Kann M., and Helenius A. Viral entry into the nucleus. Annu Rev Cell Dev Biol 16 (2000) 627-651
103. Terry L.J., Shows E.B., and Wente S.R. Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport. Science 318 5855 (2007) 1412-1416
104. D'Angelo M.A., and Hetzer M.W. Structure, dynamics and function of nuclear pore complexes. Trends Cell Biol 18 10 (2008) 456-466
105. Frey S., and Gorlich D. A saturated FG-repeat hydrogel can reproduce the permeability properties of nuclear pore complexes. Cell 130 3 (2007) 512-523
106. Patel S.S., Belmont B.J., Sante J.M., and Rexach M.F. Natively unfolded nucleoporins gate protein diffusion across the nuclear pore complex. Cell 129 1 (2007) 83-96
107. Lim R.Y., Fahrenkrog B., Koser J., Schwarz-Herion K., Deng J., and Aebi U. Nanomechanical basis of selective gating by the nuclear pore complex. Science 318 5850 (2007) 640-643
108. Gorlich D., and Kutay U. Transport between the cell nucleus and the cytoplasm. Annu Rev Cell Dev Biol 15 (1999) 607-660
109. Bernad R., Engelsma D., Sanderson H., Pickersgill H., and Fornerod M. Nup214-Nup88 nucleoporin subcomplex is required for CRM1-mediated 60 S preribosomal nuclear export. J Biol Chem 281 28 (2006) 19378-19386
110. Hutten S., and Kehlenbach R.H. Nup214 is required for CRM1-dependent nuclear protein export in vivo. Mol Cell Biol 26 18 (2006) 6772-6785
111. Engelsma D., Bernad R., Calafat J., and Fornerod M. Supraphysiological nuclear export signals bind CRM1 independently of RanGTP and arrest at Nup358. EMBO J 23 18 (2004) 3643-3652
112. Hutten S., Flotho A., Melchior F., and Kehlenbach R.H. The Nup358-RanGAP complex is required for efficient importin {alpha}/{beta}-dependent nuclear import. Mol Biol Cell 19 5 (2008) 2300-2310
113. Walther T.C., Pickersgill H.S., Cordes V.C., Goldberg M.W., Allen T.D., Mattaj I.W., et al. The cytoplasmic filaments of the nuclear pore complex are dispensable for selective nuclear protein import. J Cell Biol 158 1 (2002) 63-77
114. Strawn L.A., Shen T., Shulga N., Goldfarb D.S., and Wente S.R. Minimal nuclear pore complexes define FG repeat domains essential for transport. Nat Cell Biol 6 3 (2004) 197-206
115. Pante N., and Kann M. Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm. Mol Biol Cell 13 2 (2002) 425-434
116. Wisnivesky J.P., Leopold P.L., and Crystal R.G. Specific binding of the adenovirus capsid to the nuclear envelope. Hum Gene Ther 10 13 (1999) 2187-2195
117. Trotman L.C., Mosberger N., Fornerod M., Stidwill R.P., and Greber U.F. Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat Cell Biol 3 (2001) 1092-1100
118. Marg A., Shan Y., Meyer T., Meissner T., Brandenburg M., and Vinkemeier U. Nucleocytoplasmic shuttling by nucleoporins Nup153 and Nup214 and CRM1-dependent nuclear export control the subcellular distribution of latent Stat1. J Cell Biol 165 6 (2004) 823-833
119. Greber U.F., Willetts M., Webster P., and Helenius A. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75 (1993) 477-486
120. Hong S.S., Szolajska E., Schoehn G., Franqueville L., Myhre S., Lindholm L., et al. The 100K-chaperone protein from adenovirus serotype 2 (Subgroup C) assists in trimerization and nuclear localization of hexons from subgroups C and B adenoviruses. J Mol Biol 352 1 (2005) 125-138
121. Matthews D.A., and Russell W.C. Adenovirus protein-protein interactions: hexon and protein VI. J Gen Virol 75 (1994) 3365-3374
122. Wodrich H., Guan T., Cingolani G., Von Seggern D., Nemerow G., and Gerace L. Switch from capsid protein import to adenovirus assembly by cleavage of nuclear transport signals. EMBO J 22 23 (2003) 6245-6255
123. Greber U.F., Webster P., Weber J., and Helenius A. The role of the adenovirus protease in virus entry into cells. EMBO J 15 (1996) 1766-1777
124. Wiethoff C.M., Wodrich H., Gerace L., and Nemerow G.R. Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol 79 4 (2005) 1992-2000
125. Misteli T., Gunjan A., Hock R., Bustin M., and Brown D.T. Dynamic binding of histone H1 to chromatin in living cells. Nature 408 6814 (2000) 877-881
126. Rux J.J., and Burnett R.M. Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon. Mol Ther 1 1 (2000) 18-30
127. Saphire A.C.S., Guan T.L., Schirmer E.C., Nemerow G.R., and Gerace L. Nuclear import of adenovirus DNA in vitro involves the nuclear protein import pathway and hsc70. J Biol Chem 275 6 (2000) 4298-4304
128. Zhao L.-J., and Padmanabhan R. Nuclear transport of adenovirus DNA polymerase is facilitated by interaction with preterminal protein. Cell 55 (1988) 1005-1015
129. Xue Y., Johnson J.S., Ornelles D.A., Lieberman J., and Engel D.A. Adenovirus protein VII functions throughout early phase and interacts with cellular proteins SET and pp32. J Virol 79 4 (2005) 2474-2483
130. van Oostrum J., and Burnett R.M. Molecular composition of the adenovirus type 2 virion. J Virol 56 (1985) 439-448
131. Sung M.T., Lischwe M.A., Richards J.C., and Hosokawa K. Adenovirus chromatin I. Isolation and characterization of the major core protein VII and precursor pro-VII. J Biol Chem 252 (1977) 4981-4987
132. Hosokawa K., and Sung M.T. Isolation and characterization of an extreme basic protein from adenovirus type 5. J Virol 17 (1976) 924-934
133. Berk A.J. Adenoviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. 5 ed. (2007), Lippincott Williams & Wilkins, Philadelphia, PA, USA 2355-2436
134. Johnson J.S., Osheim Y.N., Xue Y., Emanuel M.R., Lewis P.W., Bankovich A., et al. Adenovirus protein VII condenses DNA, represses transcription, and associates with transcriptional activator E1A. J Virol 78 12 (2004) 6459-6468
135. Chatterjee P.K., Vayda M.E., and Flint S.J. Adenoviral protein VII packages intracellular viral DNA throughout the early phase of infection. EMBO J 5 7 (1986) 1633-1644
136. Lee T.W., Blair G.E., and Matthews D.A. Adenovirus core protein VII contains distinct sequences that mediate targeting to the nucleus and nucleolus, and colocalization with human chromosomes. J Gen Virol 84 Pt 12 (2003) 3423-3428
137. Hindley C.E., Lawrence F.J., and Matthews D.A. A role for transportin in the nuclear import of adenovirus core proteins and DNA. Traffic 8 10 (2007) 1313-1322
138. Haruki H., Okuwaki M., Miyagishi M., Taira K., and Nagata K. Involvement of template-activating factor I/SET in transcription of adenovirus early genes as a positive-acting factor. J Virol 80 2 (2006) 794-801
139. Spector D.J. Default assembly of early adenovirus chromatin. Virology 359 1 (2007) 116-125
140. Haruki H., Gyurcsik B., Okuwaki M., and Nagata K. Ternary complex formation between DNA-adenovirus core protein VII and TAF-Ibeta/SET, an acidic molecular chaperone. FEBS Lett 555 3 (2003) 521-527
141. Samad M.A., Okuwaki M., Haruki H., and Nagata K. Physical and functional interaction between a nucleolar protein nucleophosmin/B23 and adenovirus basic core proteins. FEBS Lett 581 17 (2007) 3283-3288
142. Spector D.J., Johnson J.S., Baird N.L., and Engel D.A. Adenovirus type 5 DNA-protein complexes from formaldehyde cross-linked cells early after infection. Virology 312 1 (2003) 204-212
143. Matthews D.A., and Russell W.C. Adenovirus core protein V is delivered by the invading virus to the nucleus of the infected cell and later in infection is associated with nucleoli. J Gen Virol 79 Part 7 (1998) 1671-1675
144. Itahana K., and Zhang Y. Mitochondrial p32 is a critical mediator of ARF-induced apoptosis. Cancer Cell 13 6 (2008) 542-553
145. Matthews D.A., and Russell W.C. Adenovirus core protein V interacts with p32-a protein which is associated with both the mitochondria and the nucleus. J Gen Virol 79 Pt 7 (1998) 1677-1685
146. Ugai H., Borovjagin A.V., Le L.P., Wang M., and Curiel D.T. Thermostability/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursor. J Mol Biol 366 4 (2007) 1142-1160
147. Barchet W., Wimmenauer V., Schlee M., and Hartmann G. Accessing the therapeutic potential of immunostimulatory nucleic acids. Curr Opin Immunol 20 4 (2008) 389-395
148. Muruve D.A., Petrilli V., Zaiss A.K., White L.R., Clark S.A., Ross P.J., et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452 7183 (2008) 103-107
149. Ojala P.M., Sodeik B., Ebersold M.W., Kutay U., and Helenius A. Herpes simplex virus type 1 entry into host cells: reconstitution of capsid binding and uncoating at the nuclear pore complex in vitro. Mol Cell Biol 20 13 (2000) 4922-4931
150. Dickmanns A., Bischoff F.R., Marshallsay C., Luhrmann R., Ponstingl H., and Fanning E. The thermolability of nuclear protein import in tsBN2 cells is suppressed by microinjected Ran-GTP or Ran-GDP, but not by RanQ69L or RanT24N. J Cell Sci 109 Pt 6 (1996) 1449-1457
151. Strang B.L., and Stow N.D. Blocks to herpes simplex virus type 1 replication in a cell line, tsBN2, encoding a temperature-sensitive RCC1 protein. J Gen Virol 88 Pt 2 (2007) 376-383
152. Hafezi W., Bernard E., Cook R., and Elliott G. Herpes simplex virus tegument protein VP22 contains an internal VP16 interaction domain and a C-terminal domain that are both required for VP22 assembly into the virus particle. J Virol 79 20 (2005) 13082-13093
153. Elliott G., Hafezi W., Whiteley A., and Bernard E. Deletion of the herpes simplex virus VP22-encoding gene (UL49) alters the expression, localization, and virion incorporation of ICP0. J Virol 79 15 (2005) 9735-9745
154. Yamauchi Y., Kiriyama K., Kubota N., Kimura H., Usukura J., and Nishiyama Y. The UL14 tegument protein of herpes simplex virus type 1 is required for efficient nuclear transport of the alpha transinducing factor VP16 and viral capsids. J Virol 82 3 (2008) 1094-1106
155. Wysocka J., and Herr W. The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. Trends Biochem Sci 28 6 (2003) 294-304
156. Batterson W., Furlong D., and Roizman B. Molecular genetics of Herpes simplex virus. VIII. Further characterization of a temperature-sensitive mutant defective in release of viral DNA and in other stages of the viral reproductive cycle. J Virol 45 (1983) 397-407
157. Feldman L., Blankenship M.L., and Ben-Porat T. Isolation and characterization of a temperature-sensitive uncoating mutant of pseudorabies virus. J Gen Virol 54 Pt 2 (1981) 333-342
158. Miyamoto K., and Morgan C. Structure and development of viruses as observed in the electron microscope. XI. Entry and uncoating of herpes simplex virus. J Virol 8 6 (1971) 910-918
159. Morgan C., Rose H.M., and Mednis B. Electron microscopy of Herpes simplex virus. I. Entry. J Virol 2 (1968) 507-516
160. Zhou Z.H., Chen D.H., Jakana J., Rixon F.J., and Chiu W. Visualization of tegument-capsid interactions and DNA in intact herpes simplex virus type 1 virions. J Virol 73 4 (1999) 3210-3218
161. Mettenleiter T.C. Budding events in herpesvirus morphogenesis. Virus Res 106 2 (2004) 167-180
162. Roberts A.P., Abaitua F., O'Hare P., McNab D., Rixon F.J., and Pasdeloup D. Differing roles of inner tegument proteins pUL36 and pUL37 during entry of herpes simplex virus type 1. J Virol 83 1 (2009) 105-116
163. Jovasevic V., Liang L., and Roizman B. Proteolytic cleavage of VP1-2 is required for release of herpes simplex virus 1 DNA into the nucleus. J Virol 82 7 (2008) 3311-3319
164. Krautwald M., Fuchs W., Klupp B.G., and Mettenleiter T.C. Translocation of incoming pseudorabies virus capsids to the cell nucleus is delayed in the absence of tegument protein pUL37. J Virol (2009)
165. Preston V.G., Murray J., Preston C.M., McDougall I.M., and Stow N.D. The UL25 gene product of herpes simplex virus type 1 is involved in uncoating of the viral genome. J Virol 82 13 (2008) 6654-6666
166. Johannsen E., Luftig M., Chase M.R., Weicksel S., Cahir-McFarland E., Illanes D., et al. Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci USA 101 46 (2004) 16286-16291
167. Kaelin K., Dezelee S., Masse M.J., Bras F., and Flamand A. The UL25 protein of pseudorabies virus associates with capsids and localizes to the nucleus and to microtubules. J Virol 74 1 (2000) 474-482
168. Cockrell S.K., Sanchez M.E., Erazo A., and Homa F.L. Role of the UL25 protein in herpes simplex virus DNA encapsidation. J Virol 83 1 (2009) 47-57
169. Newcomb W.W., Juhas R.M., Thomsen D.R., Homa F.L., Burch A.D., Weller S.K., et al. The UL6 gene product forms the portal for entry of DNA into the herpes simplex virus capsid. J Virol 75 22 (2001) 10923-10932
170. Newcomb W.W., Booy F.P., and Brown J.C. Uncoating the herpes simplex virus genome. J Mol Biol 370 4 (2007) 633-642
171. Cardone G., Winkler D.C., Trus B.L., Cheng N., Heuser J.E., Newcomb W.W., et al. Visualization of the herpes simplex virus portal in situ by cryo-electron tomography. Virology 361 2 (2007) 426-434
172. Chang J.T., Schmid M.F., Rixon F.J., and Chiu W. Electron cryotomography reveals the portal in the herpesvirus capsid. J Virol 81 4 (2007) 2065-2068
173. Lander G.C., Tang L., Casjens S.R., Gilcrease E.B., Prevelige P., Poliakov A., et al. The structure of an infectious P22 virion shows the signal for headful DNA packaging. Science 312 5781 (2006) 1791-1795
174. Oh J., and Fraser N.W. Temporal association of the herpes simplex virus genome with histone proteins during a lytic infection. J Virol 82 7 (2008) 3530-3537
175. Evilevitch A., Lavelle L., Knobler C.M., Raspaud E., and Gelbart W.M. Osmotic pressure inhibition of DNA ejection from phage. Proc Natl Acad Sci USA 100 16 (2003) 9292-9295
176. Jeembaeva M., Castelnovo M., Larsson F., and Evilevitch A. Osmotic pressure: resisting or promoting DNA ejection from phage?. J Mol Biol 381 2 (2008) 310-323
177. Shahin V., Hafezi W., Oberleithner H., Ludwig Y., Windoffer B., Schillers H., et al. The genome of HSV-1 translocates through the nuclear pore as a condensed rod-like structure. J Cell Sci 119 Pt 1 (2006) 23-30
178. Jakel S., Albig W., Kutay U., Bischoff F.R., Schwamborn K., Doenecke D., et al. The importin beta/importin 7 heterodimer is a functional nuclear import receptor for histone H1. EMBO J 18 9 (1999) 2411-2423
179. Kent J.R., Zeng P.Y., Atanasiu D., Gardner J., Fraser N.W., and Berger S.L. During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. J Virol 78 18 (2004) 10178-10186
180. Abaitua F., and O'Hare P. Identification of a highly conserved, functional nuclear localization signal within the N-terminal region of herpes simplex virus type 1 VP1-2 tegument protein. J Virol 82 11 (2008) 5234-5244
181. Smith J.L., Campos S.K., and Ozbun M.A. Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes. J Virol 81 18 (2007) 9922-9931
182. Day P.M., Lowy D.R., and Schiller J.T. Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 307 1 (2003) 1-11
183. Giroglou T., Florin L., Schafer F., Streeck R.E., and Sapp M. Human papillomavirus infection requires cell surface heparan sulfate. J Virol 75 3 (2001) 1565-1570
184. Evander M., Frazer I.H., Payne E., Qi Y.M., Hengst K., and McMillan N.A. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol 71 3 (1997) 2449-2456
185. Culp T.D., Budgeon L.R., Marinkovich M.P., Meneguzzi G., and Christensen N.D. Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol 80 18 (2006) 8940-8950
186. Pho M.T., Ashok A., and Atwood W.J. JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J Virol 74 5 (2000) 2288-2292
187. Pelkmans L., Kartenbeck J., and Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 3 5 (2001) 473-483
188. Eash S., Querbes W., and Atwood W.J. Infection of vero cells by BK virus is dependent on caveolae. J Virol 78 21 (2004) 11583-11590
189. Imperiale M., and Major E. Polyomaviruses. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. 5 ed. (2007), Lippincott Williams & Wilkins, Philadelphia, PA, USA 2263-2298
190. Yan Y., Stehle T., Liddington R.C., Zhao H., and Harrison S.C. Structure determination of simian virus 40 and murine polyomavirus by a combination of 30-fold and 5-fold electron-density averaging. Structure 4 2 (1996) 157-164
191. Clever J., Dean D.A., and Kasamatsu H. Identification of a DNA binding domain in simian virus 40 capsid proteins Vp2 and Vp3. J Biol Chem 268 28 (1993) 20877-20883
192. Kasamatsu H., and Nakanishi A. How do animal DNA viruses get to the nucleus?. Annu Rev Microbiol 52 (1998) 627-686
193. Clever J., Yamada M., and Kasamatsu H. Import of simian virus 40 virions through nuclear pore complexes. Proc Natl Acad Sci USA 88 16 (1991) 7333-7337
194. Nakanishi A., Clever J., Yamada M., Li P.P., and Kasamatsu H. Association with capsid proteins promotes nuclear targeting of simian virus 40 DNA. Proc Natl Acad Sci USA 93 1 (1996) 96-100
195. Ishii N., Minami N., Chen E.Y., Medina A.L., Chico M.M., and Kasamatsu H. Analysis of a nuclear localization signal of simian virus 40 major capsid protein Vp1. J Virol 70 2 (1996) 1317-1322
196. Ishii N., Nakanishi A., Yamada M., Macalalad M.H., and Kasamatsu H. Functional complementation of nuclear targeting-defective mutants of simian virus 40 structural proteins. J Virol 68 12 (1994) 8209-8216
197. Nakanishi A., Li P.P., Qu Q., Jafri Q.H., and Kasamatsu H. Molecular dissection of nuclear entry-competent SV40 during infection. Virus Res 124 1-2 (2007) 226-230
198. Shishido-Hara Y., Ichinose S., Higuchi K., Hara Y., and Yasui K. Major and minor capsid proteins of human polyomavirus JC cooperatively accumulate to nuclear domain 10 for assembly into virions. J Virol 78 18 (2004) 9890-9903
199. Qu Q., Sawa H., Suzuki T., Semba S., Henmi C., Okada Y., et al. Nuclear entry mechanism of the human polyomavirus JC virus-like particle: role of importins and the nuclear pore complex. J Biol Chem 279 26 (2004) 27735-27742
200. Crowther R.A., Kiselev N.A., Bottcher B., Berriman J.A., Borisova G.P., Ose V., et al. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77 6 (1994) 943-950
201. Rabe B., Glebe D., and Kann M. Lipid-mediated introduction of hepatitis B virus capsids into nonsusceptible cells allows highly efficient replication and facilitates the study of early infection events. J Virol 80 11 (2006) 5465-5473
202. Funk A., Mhamdi M., Lin L., Will H., and Sirma H. Itinerary of hepatitis B viruses: delineation of restriction points critical for infectious entry. J Virol 78 15 (2004) 8289-8300
203. Stoeckl L., Funk A., Kopitzki A., Brandenburg B., Oess S., Will H., et al. Identification of a structural motif crucial for infectivity of hepatitis B viruses. Proc Natl Acad Sci USA 103 17 (2006) 6730-6734
204. Mabit H., Breiner K.M., Knaust A., Zachmann-Brand B., and Schaller H. Signals for bidirectional nucleocytoplasmic transport in the duck hepatitis B virus capsid protein. J Virol 75 4 (2001) 1968-1977
205. Kann M., Sodeik B., Vlachou A., Gerlich W.H., and Helenius A. Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex. J Cell Biol 145 1 (1999) 45-55
206. Steven A.C., Conway J.F., Cheng N., Watts N.R., Belnap D.M., Harris A., et al. Structure, assembly, and antigenicity of hepatitis B virus capsid proteins. Adv Virus Res 64 (2005) 125-164
207. Kann M., Schmitz A., and Rabe B. Intracellular transport of hepatitis B virus. World J Gastroenterol 13 1 (2007) 39-47
208. Lill Y., Lill M.A., Fahrenkrog B., Schwarz-Herion K., Paulillo S., Aebi U., et al. Single hepatitis-B virus core capsid binding to individual nuclear pore complexes in Hela cells. Biophys J 91 8 (2006) 3123-3130
209. Fanning E., and Zhao K. SV40 DNA replication: from the A gene to a nanomachine. Virology (2008)
210. Endter C., and Dobner T. Cell transformation by human adenoviruses. Curr Top Microbiol Immunol 273 (2004) 163-214
211. Damania B. Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis. Nat Rev Microbiol 2 8 (2004) 656-668
212. Kutok J.L., and Wang F. Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol 1 (2006) 375-404
213. Tsygankov A.Y. Cell transformation by Herpesvirus saimiri. J Cell Physiol 203 2 (2005) 305-318
214. Simas J.P., and Efstathiou S. Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends Microbiol 6 7 (1998) 276-282
215. Ganem D. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol 1 (2006) 273-296
216. Howley P., and Lowy D. Papillomaviruses. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. 5 ed. (2007), Lippincott Williams & Wilkins, Philadelphia, PA, USA 2299-2354
217. Ahuja D., Saenz-Robles M.T., and Pipas J.M. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24 52 (2005) 7729-7745
218. Fioriti D., Degener A.M., Mischitelli M., Videtta M., Arancio A., Sica S., et al. BKV infection and hemorrhagic cystitis after allogeneic bone marrow transplant. Int J Immunopathol Pharmacol 18 2 (2005) 309-316
219. Khalili K., Del Valle L., Otte J., Weaver M., and Gordon J. Human neurotropic polyomavirus, JCV, and its role in carcinogenesis. Oncogene 22 33 (2003) 5181-5191
220. Fluck M.M., and Haslam S.Z. Mammary tumors induced by polyomavirus. Breast Cancer Res Treat 39 1 (1996) 45-56
221. Scherneck S., Ulrich R., and Feunteun J. The hamster polyomavirus-a brief review of recent knowledge. Virus Genes 22 1 (2001) 93-101
222. Azam F., and Koulaouzidis A. Hepatitis B virus and hepatocarcinogenesis. Ann Hepatol 7 2 (2008) 125-129
223. Kulkarni K., Jacobson I.M., and Tennant B.C. The role of the woodchuck model in the treatment of hepatitis B virus infection. Clin Liver Dis 11 4 (2007) 707-725 vii
224. Sabourdy F., Casteignau A., Gelfi J., Deceroi S., Delverdier M., and Messud-Petit F.L. Tumorigenic poxviruses: growth factors in a viral context?. J Gen Virol 85 Pt 12 (2004) 3597-3606
225. McFadden G. Poxvirus tropism. Nat Rev Microbiol 3 3 (2005) 201-213
226. Hanson D., and Diven D.G. Molluscum contagiosum. Dermatol Online J 9 2 (2003) 2
227. Chang W., Macaulay C., Hu S.L., Tam J.P., and McFadden G. Tumorigenic poxviruses: characterization of the expression of an epidermal growth factor related gene in Shope fibroma virus. Virology 179 2 (1990) 926-930
228. Niven J.S., Armstrong J.A., Andrewes C.H., Pereira H.G., and Valentine R.C. Subcutaneous "growths" in monkeys produced by a poxvirus. J Pathol Bacteriol 81 (1961) 1-14
229. Cheevers W.P., O'Callaghan D.J., and Randall C.C. Biosynthesis of host and viral deoxyribonucleic acid during hyperplastic fowlpox infection in vivo. J Virol 2 5 (1968) 421-429
230. Pyeon D., Pearce S.M., Lank S.M., Ahlquist P., and Lambert P.F. Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog 5 2 (2009) e1000318